Nutritional supplements in critical illness

AACN Advanced Critical Care

Volumn 22, Issue 4, 2011, Pages 301-316

  Hayes, Genevieve Luehrs ^a   McKinzie, Brian P ^a   Bullington, Wendy Moore ^a   Cooper, Tanna B ^a   Pilch, Nicole Ann ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

critical illness; glutamine; nutrition; omega 3 fatty acids; supplements

Indexed keywords

ANDROGEN; ARGININE; FISH OIL; GLUTAMINE; PROBIOTIC AGENT; SELENIUM; ZINC;

CONTINUING EDUCATION; CRITICAL ILLNESS; DIET SUPPLEMENTATION; DIETARY FIBER; HUMAN; REVIEW;

ANDROGENS; ARGININE; CRITICAL ILLNESS; DIETARY FIBER; DIETARY SUPPLEMENTS; EDUCATION, CONTINUING; FISH OILS; GLUTAMINE; HUMANS; PROBIOTICS; SELENIUM; ZINC;

EID: 81255188531     PISSN: 15597768     EISSN: 15597776     Source Type: Journal    
DOI: 10.1097/NCI.0b013e31822c371b     Document Type: Article

References (146)

1. Heyland DK, Dhaliwal R, Drover JW, et al. Clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN. 2003;27(5): 355-373. Also available at http://www.criticalcarenutrition com/docs/cpg/protocolrev.pdf. Updated May 2009.
2. Dupertuis YM, Meguid MM, Pichard C. Advancing from immunonutrition to pharmaconutrition: A gigantic challenge. Curr Op Clin Nutr Metab Care. 2009;12:398-403.
3. McClave SA, Martindale RG, Vanek VW, et al; American Society for Parenteral and Enteral Nutrition board of directors, American College of Critical Care Medicine, Society of Critical Care Medicine. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN. 2009;33:277-316.
4. Kreymann KG, Berger MM, Deutz NEP. ESPEN guidelines on enteral nutrition: Intensive care. Clin Nutr. 2006;25:210-223.
5. Singer P, Berger MM, Van den Berghe G, et al. ESPEN guidelines on parenteral nutrition: Intensive care. Clin Nutr. 2009;28:387-400.
6. Tjader I, Berg A, Wernerman, J. Exogenous glutamine- Compensating a shortage? Crit Care Med. 2007;35(suppl): S553-S556.
7. Savy GK. Glutamine supplementation: Heal the gut, help the patient. J Infus Nurs. 2002;25(1):65-69.
8. Wischmeyer PE. Glutamine: Mode of action in critical illness. Crit Care Med. 2007;35(suppl):S541-S544.
9. Bongers T, Griffiths RD, McArdle A. Exogenous glutamine: The clinical evidence. Crit Care Med. 2007;35(suppl): S545-S552.
10. Wischmeyer PE. Glutamine: Role in critical illness and ongoing clinical trials. Curr Op Gastroenterol. 2008;24: 190-197.
11. Novak F, Heyland DK, Avenell A, Drover JW, Su X. Glutamine supplementation in serious illness: A systematic review of the evidence. Crit Care Med. 2002;30:2022-2029.
12. Zhou Y, Jiang Z, Sun Y, Wang X, Ma E, Wilmore D. The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: A randomized, double-blind, controlled clinical trial. JPEN. 2003;27(4):241-245.
13. Peng X, Yan H, You Z, Wang P, Wang S. Effects of enteral supplementation with glutamine granules on intestinal mucosal barrier function in severe burned patients. Burns. 2004;30:135-139.
14. Garrel D, Patenaude J, Nedelec B, et al. Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: A prospective, controlled, randomized clinical trial. Crit Care Med. 2003;31:2444-2449.
15. Juang P, Fish DN, Jung R, MacLaren R. Enteral glutamine supplementation in critically ill patients with burn injuries: A retrospective case-control evaluation. Pharmacotherapy. 2007;27(1):11-19.
16. Wischmeyer PE, Lynch J, Liedel J, et al. Glutamine administration reduces gram-negative bacteremia in severely burned patients: A prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med. 2001;29:2075-2080.
17. Houdijk APJ, Rijnsburger ER, Jansen J, et al. Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet. 1998;352:772-776.
18. McQuiggan M, Kozar R, Sailors RM, Ahn C, McKinley B, Moore F. Enteral glutamine during active shock resuscitation is safe and enhances tolerance of enteral feeding. JPEN. 2008;32(1):28-35.
19. Goeters C, Wenn A, Mertes N, et al. Parenteral L-alanyl-Lglutamine improves 6-month outcome in critically ill patients. Crit Care Med. 2002;30:2032-2037.
20. Ockenga J, Borchert K, Rifai K, Manns MP, Bischoff SC. Effect of glutamine-enriched total parenteral nutrition in patients with acute pancreatitis. Clin Nutr. 2002;21(5):409-416.
21. Fuentes-Orozco C, Cervantes-Guevara G, Mucino-Hernandezz I, et al. L-alanyl-L-glutamine-supplemented parenteral nutrition decreases infectious morbidity rate in patients with severe acute pancreatitis. JPEN. 2008;32(4):403-411.
22. Sahin H, Mercanligil SM, Inac N, Ok E. Effects of glutamine-enriched total parenteral nutrition on acute pancreatitis. Eur J Clin Nutr. 2007;61:1429-1434.
23. Jiang Z, Jiang H, Furst P. The impact of glutamine dipeptides on outcome of surgical patients: Systematic review of randomized controlled trials from Europe and Asia. Clin Nutr Supp. 2004;1:17-23.
24. Estivariz CF, Griffith DP, Luo M, et al. Efficacy of parenteral nutrition supplemented with glutamine dipeptide to decrease hospital infections in critically ill surgical patients. JPEN. 2008;32(4):389-402.
25. Oguz M, Kerem M, Bedirli A, et al. L-alanin-L-glutamine supplementation improves the outcome after colorectal surgery for cancer. Colorec Dis. 2007;9:515-520.
26. Neri A, Mariani F, Piccolomini A, Testa M, Vuolo G, Di Cosmo L. Glutamine-supplemented total parenteral nutrition in major abdominal surgery. Nutr. 2001;17(11/12):968-969.
27. Luo M, Bazargan N, Griffith DP, et al. Metabolic effects of enteral versus parenteral alanyl-glutamine dipeptide administration in critically ill patients receiving enteral feeding: A pilot study. Clin Nutr. 2008;27:297-306.
28. Spitter A, Sautner T, Gornikiewicz A, et al. Postoperative glycyl-glutamine infusion reduces immunosuppression: Partial prevention of the surgery induced decrease in HLADR expression on monocytes. Clin Nutr. 2001;20(1): 37-42.
29. Mertes N, Schulzki C, Goeters C, et al. Cost containment through L-alanyl-L-glutamine supplemented total parenteral nutrition after major abdominal surgery: A prospective randomized double-blind controlled study. Clin Nutr. 2000;19(6):395-401.
30. Powell-Tuck J, Jamieson CP, Bettany GEA, et al. A double blind, randomized, controlled trial of glutamine supplementation in parenteral nutrition. Gut. 1999;45:82-88.
31. Griffiths RD, Jones C, Palmer TEA. Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition. Nutr. 1997;13:295-302.
32. Dechelotte P, Hasselmann M, Cynober L, et al. L-alanyl-Lglutamine dipeptide-supplemented total parenteral nutrition reduces infectious complications and glucose intolerance in critically ill patients: The French controlled, randomized, double-blind, multicenter study. Crit Care Med. 2006;34:598-604.
33. Fuentes-Orozco C, Anaya-Prado R, Gonzalez-Ojeda A, et al. L-alanyl-L-glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis. Clin Nutr. 2004;23:13-21.
34. Conejero R, Bonet A, Grau T, et al. Effect of a glutamineenriched enteral diet on intestinal permeability and infectious morbidity at 28 days in critically ill patients with systemic inflammatory response syndrome: A randomized, single-blind, prospective, multicenter study. Nutr. 2002;18:716-721.
35. Jones C, Palmer TEA, Griffiths RD. Randomized clinical outcome study of critically ill patients given glutaminesupplemented enteral nutrition. Nutr. 1999;15(2):108-115.
36. Avenell A. Current evidence and ongoing trials on the use of glutamine in critically-ill patients and patients undergoing surgery. Pro Nutr Soc. 2009;68:261-268.
37. Hall JC, Dobb G, Hall J, de Sousa R, Brennan L, McCauley R. A prospective randomized trial of enteral glutamine in critical illness. Intensive Care Med. 2003;29:1710-1716.
38. Avenell A. Glutamine in critical care: Current evidence from systematic reviews. Pro Nutr Soc. 2006;65: 236-241.
39. Tjader I, Rooyackers O, Forsberg A, Vesali RF, Garlick PJ, Wernerman J. Effects on skeletal muscle of intravenous glutamine supplementation to ICU patients. Intensive Care Med. 2004;30:266-275.
40. Vermeulen MAR, van de Poll MCG, Ligthart-Melis GC, et al. Specific amino acids in the critically ill patient- Exogenous glutamine/arginine: A common denominator? Crit Care Med. 2007;35(suppl):S568-S576.
41. Zhou M, Martindale RG. Arginine in the critical care setting. J Nutr. 2007;137:1687s-1692s.
42. Luiking YC, Deutz NEP. Exogenous arginine in sepsis. Crit Care Med. 2007;35(suppl):S557-S563.
43. Barbul A, Uliyargoli A. Use of exogenous arginine in multiple organ dysfunction syndrome and sepsis. Crit Care Med. 2007;35(suppl):S564-S567.
44. Dupertuis YM, Meguid MM, Pichard C. Advancing from immunonutrition to a pharmaconutrition: A gigantic challenge. Curr Op Clin Nutr Metab Care. 2009;12: 398-403.
45. McNabb B, Isakow W. Probiotics for the prevention of nosocomial pneumonia: Current evidence and opinions. Curr Opin Pulm Med. 2008;14:168-175.
46. Watkinson PJ, Barber VS, Dark P, Young JD. The use of pre-, pro-, and synbiotics in adult intensive care unit patients: Systematic review. Clin Nutr. 2007;26: 182-192.
47. Koretz RL. Probiotics, critical illness, and methodologic bias. Nutr Clin Pract. 2009;24:45-49.
48. Madsen K. Probiotics in critically ill patients. J Clin Gastroenterol. 2008;42:S116-S118.
49. McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic-associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol. 2006;101:812-822.
50. Hickson M, D'Souza AL, Muthu N, et al. Use of probiotic Lactobacillus preparation to prevent diarrhea associated with antibiotics: Randomized double-blind placebocontrolled trial. BMJ. 2007;335:80.
51. Giamarellos-Bourboulis EJ, Bengmark S, Kanellakopoulou K, Kotzampassi K. Pro- and synbiotics to control inflammation and infection in patients with multiple injuries. J Trauma. 2009;67:815-821.
52. Siempos II, Ntaidou TK, Flagas ME. Impact of the administration of probiotics on the incidence of ventilatorassociated pneumonia: A meta-analysis of randomized controlled trials. Crit Care Med. 2010;38(3):954-962.
53. Barraud D, Blard C, Hein F, et al. Probiotics in the critically ill patient: A double-blind, randomized, placebocontrolled trial. Intensive Care Med. 2010;36:1540-1547.
54. Husni RN, Gordon SM, Washington JA, et al. Lactobacillus bacteremia and endocarditis: Review of 45 cases. Clin Infect Dis. 1997;25:1048-1055.
55. Jones SD, Fullerton DA, Zamora MR, et al. Transmission of Lactobacillus pneumonia by a transplanted lung. Ann Thorac Surg. 1994;58:887-889.
56. Patel R, Cockerill FR, Parayko MK, et al. Lactobacillemia in liver transplant patients. Clin Infect Dis. 1994;18:207-212.
57. Besselink MG, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: A randomized, double-blind, placebo-controlled trial. Lancet. 2008;371:651-659.
58. Rohde CL, Bartolini V, Jones N. The use of probiotics in the prevention and treatment of antibiotic-associated diarrhea with special interest in Clostridium difficile- associated diarrhea. Nutr Clin Pract. 2009;24:33-40.
59. Weisen P, Van Gossum A, Preiser JC. Diarrhea in the critically ill. Curr Opin Crit Care. 2006;12:149-154.
60. Spapen H, Diltoer M, Van Malderen C, et al. Soluble fiber reduces the incidence of diarrhea in septic patients receiving total enteral nutrition: A prospective, double-blind, randomized, and controlled trial. Clin Nutr. 2001;20(4):301-305.
61. Rushdi T, Pichard C, Khater Y. Control of diarrhea by fiberenriched diet in ICU patients on enteral nutrition: A prospective randomized controlled trial. Clin Nutr. 2004;23:1344-1352.
62. Avenell A, Noble DW, Barr J, Englehardt T. Selenium supplementation for critically ill adults. Cochrane Database Syst Rev. 2004;(4): CD003703. doi: 10.1002/ 14651858.CD003703.pub2.
63. Vincent J, Forceville X. Critically elucidating the role of selenium. Curr Opin Anesthesiol. 2008;21:148-154.
64. Forceville X, Vitoux D, Gauzit R, Combes A, Lahilaire P, Chappuis P. Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients. Crit Care Med. 1998;26:1536-1544.
65. Heyland DK, Dhaliwal R, Suchner U, Berger M. Antioxidant nutrients: A systemic review of trace elements and vitamins in the critically ill patient. Intensive Care Med. 2005;31:327-337.
66. Manzanares W, Hardy G. Selenium supplementation in the critically ill: Posology and pharmacokinetics. Curr Opin Clin Nutr Metab Care. 2009;12:273-280.
67. Angstwurm WA, Gaertner R. Practicalities of selenium supplementation in critically ill patients. Curr Opin Clin Nutr Metab Care. 2006;9:233-238.
68. Angstwurm MW, Engelmann L, Zimmermann T, et al. Selenium in intensive care (SIC): Results of a prospective randomized, placebo-controlled, multiple center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med. 2007;35(1):118-126.
69. Jellin JM, Gregory PJ, eds. Pharmacist's Letter/Prescriber's Letter Natural Medicines Comprehensive Database. 11th ed. Stockton, CA: Therapeutic Research Faculty; 2009:1439-1445.
70. Spiller HA, Pfiefer E. Two fatal cases of selenium toxicity. Forensic Sci Int. 2007;171:67-72.
71. Collins N. Zinc supplementation: Yea or nay? J WOCN. 2003;30:295-299.
72. National Institutes of Health Clinical Center. Facts about dietary supplements: Zinc. http://www.cc.nih.gov/ccc/ supplements:zinc.pdf. Accessed May 10, 2010.
73. Lansdown AB. Zinc in the healing wound. Lancet. 1996;347:706-707.
74. Henzel JH, DeWeese MS, Lichti EL. Zinc concentrations with healing wounds. Arch Surg. 1970;100:349-357.
75. Brandrup F, Menné T, Ågren MS, Strömberg HE, Holst R, Frisén M. A randomized trial of two occlusive dressings in the treatment of leg ulcers. Acta Derm Venerol. 1990;70:231-235.
76. Strömberg HE, Ågren MS. Topical zinc oxide treatment improves arterial and venous leg ulcers. Br J Dermatol. 1984;111:461-468.
77. Raffoul W, Far MS, Cayeux MC, Berger MM. Nutritional status and food intake in nine patients with chronic low-limb ulcers and pressure ulcers: Importance of oral supplements. Nutrition. 2006;22:82-88.
78. Ågren MS, Ostenfeld U, Kallehave F, et al. A randomized, double-blind, placebo-controlled multicenter trial evaluating topical zinc oxide for acute open wounds following pilonidal disease excision. Wound Rep Reg. 2006;14:526-535.
79. Gang RK. Adhesive zinc tape in burns: Results of a clinical trial. Burns. 1980;7:322-325.
80. Wilkinson EA, Hawke CI. Does oral zinc aid the healing of chronic leg ulcers? A systematic literature review. Arch Dermatol. 1998;134:1556-1560.
81. Berger MM, Baines M, Raffoul W, et al. Trace element supplementation after major burns modulates antioxidant status and clinical course by way of increased tissue trace element concentrations. Am J Clin Nutr. 2007;85:1293-1300.
82. Berger MM, Spertini F, Shenkin A, et al. Trace element supplementation modulates pulmonary infection rates after major burns: A double-blind, placebo-controlled trial. Am J Clin Nutr. 1998;68:365-371.
83. Heyland DK, Jones N, Cvijanovich NZ, Wong H. Zinc supplementation in critically ill patients: A key pharmaconutrient? JPEN. 2008;32:509-519.
84. Wilkinson EAJ, Hawke CC. Oral zinc for arterial and venous leg ulcers. Cochrane Database Syst Rev. 1998;4:DOI: 10.1002/14651858.CD001273.
85. Zinc. In: Facts & Comparisons [database on the Internet]. St. Louis, MO: Wolters Kluwer Health; 2010. http:// online.factsandcomparisons.com. Updated February 2000. Accessed May 27, 2010.
86. Bilici M, Yildirim F, Kandil S, et al. Double-blind, placebocontrolled study of zinc sulfate in the treatment of attention deficit hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:181-190.
87. Fosmire GJ. Zinc toxicity. Am J Clin Nutr. 1990;51: 225-227.
88. Barceloux DG. Zinc. J Toxicol Clin Toxicol. 1999;37:279-292.
89. Kugelmas M. Preliminary observation: Oral zinc sulfate replacement is effective in treating muscle cramps in cirrhotic patients. J Am Coll Nutr. 2000;19:13-15.
90. Lewis MR, Kokan L. Zinc gluconate: Acute ingestion. J Toxicol Clin Toxicol. 1998;36(1/2):99-101.
91. Forman WB, Sheehan D, Cappelli S, Coffman B. Zinc abuse-an unsuspected cause of sideroblastic anemia. West J Med. 1990;152:190-192.
92. Hoffman HN II, Phyliky RL, Fleming CR. Zinc-induced copper deficiency. Gastroenterol. 1988;94:508-512.
93. Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academy Press; 2002. Also available at www.nap.edu/books/ 0309072794/html/.
94. Chandra RK. Excessive intake of zinc impairs immune responses. JAMA. 1984;252:1443-1446.
95. Godfrey HR, Godfrey NJ, Godfrey JC, Riley D. A randomized clinical trial on the treatment of oral herpes with topical zinc oxide/glycine. Altern Ther Health Med. 2001;7:49-56.
96. Zinc. In: Natural Medicines Comprehensive Database [database on Internet]. Stockton, CA: Therapeutic Research; 2010. http://naturaldatabase.com. Updated May 5, 2010. Accessed M ay 5, 2010.
97. Wilkinson EA, Hawke CI. Does oral zinc aid the healing of chronic leg ulcers? A systematic literature review. Arch Dermatol. 1998;134:1556-1560.
98. Gray M. Does oral zinc supplementation promote the healing of chronic wounds? J WOCN. 2003;30:295-299.
99. Scholl D, Langkamp-Henken B. Nutrient recommendations for wound healing. J Intravenous Nurs. 2001;24(2):124-132.
100. Young B, Ott L, Kasarskis E, et al. Zinc supplementation is associated with improved neurologic recovery rate and visceral protein levels of patients with severe closed head injury. J Neurotrauma. 1996;13:25-34.
101. Berger MM, Soguel L, Shenkin A, et al. Influence of early antioxidant supplements on clinical evolution and organ function in critically ill cardiac surgery, major trauma, and subarachnoid hemorrhage patients. Crit Care. 2008;12(4):R101.
102. Hallbook T, Lanner E. Serum-zinc and healing of venous ulcers. Lancet. 1972;2(7781):780-782.
103. Haeger K, Lanner E. Oral zinc sulphate in the treatment of ischaemic leg ulcers. VASA. 1974;3(1):77-81.
104. Haeger K, Lanner E, Magnusson PO. Oral zinc sulphate in the treatment of venous leg ulcers. VASA. 1972;1(1):62-69.
105. Pories WJ, Henzel JH, Rob CG, Strain WH. Acceleration of wound healing in man with zinc sulphate given by mouth. Lancet. 1967;1(7842):121-124.
106. Demling RH. The use of anabolic agents in catabolic states. J Burns Wounds. 2007;6:e2.
107. Demling RH. The role of anabolic hormones for wound healing in catabolic states. J Burns Wounds. 2005; 17(4):e2.
108. Demling RH. Oxandrolone, an anabolic steroid, enhances the healing of a cutaneous wound in the rat. Wound Repair Regen. 2000;8(2):97-102.
109. Jeschke MG, Finnerty CC, Suman OE, Kulp G, Mlcak RP, Herndon DN. The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase post-burn. Ann Surg. 2007;246: 351-362.
110. Wolf SE, Edelman LS, Kemalyan N, et al. Effects of oxandrolone on outcome measures in the severely burned: A multicenter prospective randomized doubleblind trial. J Burn Care Res. 2006;27:131-139.
111. Pham TN, Klein MB, Gibran NS, et al. Impact of oxandrolone treatment on acute outcomes after severe burn injury. J Burn Care Res. 2008;29:902-906.
112. Miller JT, Btaiche IF. Oxandrolone treatment in adults with severe thermal injury. Pharmacotherapy. 2009;29(2):213-226.
113. McCullough MC, Namais N, Schulman C, et al. Incidence of hepatic dysfunction is equivalent in burn patients receiving oxandrolone and controls. J Burn Care Res. 2007;28:412-420.
114. Fetterman JW, Zdanowicz MM. Therapeutic potential of omega-3 polyunsaturated fatty acids in disease. Am J Health-Syst Pharm. 2009;66:1169-1179.
115. Pepping J. Omega-3 essential fatty acids. Am J Health Syst Pharm. 1999;56:719-720, 723-724.
116. Breslow JL. Omega-3 fatty acids and cardiovascular disease. Am J Clin Nutr. 2006;83:1477S-1482S.
117. Calder PC. Omega-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83:1505S-1519S.
118. Heller AR, Rössler S, Litz RJ, et al. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med. 2006;34:972-979.
119. Tsekos E, Reuter C, Stehle P, Boeden G. Perioperative administration of parenteral fish oil supplements in a routine clinical setting improves patient outcome after major abdominal surgery. Clin Nutr. 20004;23:325-330.
120. Mayer K, Gokorsch S, Fegbeutel C, et al. Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. Am J Respir Crit Care Med. 2003;167:1321-1328.
121. Caló L, Bianconi L, Colivicchi F, et al. N-3 fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: A randomized, controlled trial. J Am Coll Cardiol. 2005;45:1723-1728.
122. Waitzberg DL, Torrinhas RS. Fish oil lipid emulsions and immune response: What clinicians need to know. Nutr Clin Pract. 2009;24:487-499.
123. Calder PC, Deckelbaum RJ. Dietary lipids: More than just a source of calories. Curr Opin Clin Nutr Met Care. 1999;2:105-107.
124. Trebble TM, Wootton SA, Miles EA, et al. Prostaglandin E2 production and T cell function after fish-oil supplementation: Response to antioxidant co-supplementation. Am J Clin Nutr. 2003;78:376-382.
125. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. NEJM. 1989;320:265-271.
126. Mayer K, Fegbeutel C, Hattar K, et al. Omega-3 vs omega-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: Impact on plasma fatty acids and lipid mediator generation. Intensive Care Med. 2003;29:1472-1481.
127. Moran V, Grau T, deLorenzo AG, et al. Effect of an enteral feeding with eicosapentaenoic and gamma-linolenic acids on the outcome of mechanically ventilated critically ill septic patients. Crit Care Med. 2006;34:A70.
128. Singer P, Theilla M, Fisher H, Gibstein L, Grozovski E, Cohen J. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med. 2006;34:1033-1038.
129. Gadek J, DeMichele SJ, Karlstad M, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Crit Care Med. 1999;27:1409-1420.
130. Pontes-Arruda A, Aragão AM, Albuquerque JD. Effects of enteral feeding with eicosapentaenoic acid, gammalinolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med. 2006;34:2325-2333.
131. Marik PE, Zaloga GP. Immunonutrition in critically ill patients: A systematic review and analysis of the literature. Intensive Care Med. 2008;34:1980-1990.
132. Galbán C, Montejo JC, Mesejo A, et al. An immuneenhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients. Crit Care Med. 2000;28(3):643-648.
133. Radrizzani D, Bertolini G, Facchini R, et al. Early enteral immunonutrition vs parenteral nutrition in critically ill patients without severe sepsis: A randomized clinical trial. Intensive Care Med. 2006;32:1191-1198.
134. Heller AR, Fischer S, Rössel T, et al. Impact of n-3 fatty acid supplemented parenteral nutrition on haemostasis patterns after major abdominal surgery. Br J Nutr. 2002;87:S95-S101.
135. Wichmann MW, Thul P, Czarnetzki HD, Morlion BJ, Kemen M, Jauch KW. Evaluation of clinical safety and beneficial effects of a fish oil containing lipid emulsion (Lipoplus, MLF541): Data from a prospective, randomized, multicenter trial. Crit Care Med. 2007;35:700-706.
136. Wang X, Li W, Li N, Li J. Omega-3 fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: A randomized and controlled study. JPEN. 2008;32:236-241.
137. Heller AR, Rössler S, Litz RJ, et al. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med. 2006;34:972-979.
138. Gogos CA, Ginopoulos P, Salsa B, et al. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: A randomized control trial. Cancer. 1998;82:395-402.
139. Jalili M, Dehpour AR. Extremely prolonged INR associated with warfarin in combination with both trazodone and omega-3 fatty acids. Arch Med Res. 2007;38:901-904.
140. Buckley MS, Goff AD, Knapp WE. Fish oil interaction with warfarin. Ann Pharmacother. 2004;38:50-53.
141. Bender NK, Kraynak MA, Chiquette E, et al. Effects of marine fish oils on the anticoagulation status of patients receiving chronic warfarin therapy. J Thromb Thrombolysis. 1998;5:257-261.
142. Singer P, Melzer S, Goschel M, Augustin S. Fish oil amplifies the effect of propranolol in mild essential hypertension. Hypertension. 1990;16:682-691.
143. Lungershausen YK, Abbey M, Nestel PJ, Howe PR. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives. J Hypertension. 1994;12:1041-1045.
144. Vessby B, Boberg M. Dietary supplementation with n-3 fatty acids may impair glucose homeostasis in patients with non-insulin-dependent diabetes mellitus. J Int Med. 1990;228:165-171.
145. Abbott Nutrition for Healthcare Professionals. Abbott Web site. http://abbottnutrition.com/Our-Products/Our- Products.aspx. Accessed June 21, 2011.
146. Nestlé HealthCare Nutrition Products. Nestlé Nutrition Web site. http://www.nestle-nutrition.com/Products /Default.aspx. Accessed June 21, 2011.